UAB researchers find a chemical pathway — a glutamate transporter — that may be causing seizures and shorten survival rates for patients with brain tumors.

UAB is one of five centers named to host the first class of fellows in the Edmond J. Safra Fellowship in Movement Disorders.

Published in Faculty Excellence
UAB has established the third multidisciplinary comprehensive clinic in the world for transverse myelitis, a rare spinal cord disease.
Published in Focus on Patient Care
UAB has received prestigious designation as a Comprehensive Stroke Center from the Joint Commission and American Heart Association.
Published in Focus on Patient Care
Research to identify a new approach to treat Alzheimer’s disease gets new funding after a pilot grant from the Alabama Drug Discovery Alliance.
This interdisciplinary symposium will highlight different areas of research from across campus.
The UAB studies are designed to test the safety and tolerability of CBD oil in patients with intractable seizures. CBD oil, a derivative of the cannabis plant, is delivered orally as an oily liquid.
Published in Focus on Patient Care
UAB neurology researcher Kristen Triebel gets substantial American Cancer Society grant to investigate the ability of patients to understand, choose and consent to treatment.
Published in Focus on Patient Care
Thirty honors students and faculty traveled to the National Collegiate Honors Council in November.
Published in Student Experience

Best of 2014 2

The first patient in the Southeast to get the RNS responsive neurostimulation seizure-control device implanted in the brain reports dramatic results at UAB.

Published in Focus on Patient Care
UAB has launched one of the first clinics in the nation designed to provide healthy adults with an assessment of their risk for Alzheimer’s disease.
Published in Focus on Patient Care
A ramped-up immune response may play a major role in autism disorders, according to a new study from UAB and Johns Hopkins.
A new UAB study reports on a potential new treatment for frontotemporal dementia, the second most common type after Alzheimer’s disease.

UAB researchers present warning signs that can be seen when an older adult begins to lose the ability to manage finances – which could indicate dementia.

Published in News You Can Use
Philanthropic support has enabled the UAB Department of Neurology to make huge strides in knowledge of diseases such as Parkinson’s.
Brain tumor research will benefit from a 5K and 1-mile fun run.
Published in Service to Community

The eye is a window to the brain; scientists discover early signs of dementia in changes to neurons in the eye’s retina.

UAB is the first medical center in the Southeast to implant a new type of electrical stimulator to control seizures in patients with epilepsy.
Research in personalized medicine, health informatics and genomic medicine spans disciplines and will impact the treatment of many diseases.
New drugs to slow or even prevent Parkinson’s could be in human studies as early as 2015.
Page 1 of 4
Back to Top